Results 11 to 20 of about 1,097,021 (302)
Checkpoint Inhibitors and the Gut [PDF]
Checkpoint inhibitors have revolutionized treatments in modern oncology, including many conditions previously relegated to palliative therapies only. However, emerging recognition of checkpoint inhibitor-related adverse events has complicated the status of checkpoint inhibitor-related therapies.
Tuan Tran +2 more
openaire +5 more sources
Immune checkpoint inhibitors [PDF]
Hui details the cell biology underlying the action of immune checkpoint inhibitors.
Hui, Enfu, Enfu Hui
openaire +6 more sources
Nephrotoxicity of checkpoint inhibitors; a current challenge [PDF]
Immune checkpoint inhibitors work by blocking the "checkpoint" mechanism that tumors use to hide from the immune system, therefore also weakening the immune system.
Samaneh Zandifar +4 more
doaj +3 more sources
Cell cycle ckeckpoints are activated in response to DNA damage. Their role consists in blocking the cell cycle to allow time for DNA repair. The activity of the G1 checkpoint is dependent on the p53 protein. In more than 50% of human tumor cells, the p53 gene is mutated. In the p53 mutated cells, the G1 checkpoint is lacking.
Prudhomme, Michelle
core +5 more sources
The role of immune checkpoint inhibitors in prostate cancer [PDF]
Introduction Prostate cancer (PC) is the most commonly diagnosed malignant tumour and the third cause of cancer deaths among men in Europe. The treatment of early-stage PC is very effective and in many cases allows achievement of a complete cure, whereas
Gabriel Surdacki +4 more
doaj +2 more sources
An overview of immune checkpoint inhibitors in breast cancer [PDF]
Although breast cancer is not traditionally considered an immunogenic type of tumor, the combination of immunotherapy and chemotherapy has recently emerged as a novel treatment option in triple-negative subtype in the advanced setting and other similar ...
Federica Miglietta +4 more
doaj +2 more sources
Negative Immune Checkpoint Inhibitors
Checkpoint inhibitors are a modern therapeutic approach for treating various types of cancer, metabolic diseases, and chronic infections. The main goal of this therapy is to specifically unlock the immune system, allowing it to recognize and eliminate cancer cells or pathogens, primarily through the activation of T lymphocytes.
Magda Drewniak-Świtalska +2 more
openaire +5 more sources
Checkpoint Inhibitors and Hepatotoxicity [PDF]
Uncontrolled immune response to a pathogen or any protein can lead to tissue damage and autoimmune diseases, that represent aberrant immune responses of the individual to its own cells and/or proteins. The immune checkpoint system is the regulatory mechanism that controls immune responses.
Stephen D. H. Malnick +2 more
openaire +3 more sources
Immune checkpoint inhibitors [PDF]
Three papers by James Allison and Tasuku Honjo published in JEM between 1995 and 2000 crystallized seminal insights into the role of CTLA-4 and PD-1 in immunosuppression (Krummel and Allison. 1995. J. Exp. Med.https://doi.org/10.1084/jem.182.2.459; van Elsas et al. 1999. J. Exp. Med.https://doi.org/10.1084/jem.190.3.355; Freeman et al. 2000. J.
Kroemer, Guido, Zitvogel, Laurence
openaire +3 more sources
Immune Checkpoint Inhibitors and the Heart [PDF]
Immune checkpoint inhibitors (ICIs) represent a break-through treatment for a large number of cancer types. This treatment is increasingly being recommended. ICIs are prescribed for primary tumours and for metastases, adjuvant/neo-adjuvant therapy.
Diana Larisa Mocan-Hognogi +11 more
openaire +3 more sources

